Medicamen Biotech Limited has planned a partial shutdown of its plant at Bhiwadi (Rajasthan) for 4 to 6 weeks. During the shutdown following 3 areas will be taken up for upgradation as per CGMP norms, which are expected to be completed in 4 to 6 weeks.
- Beta Lactum block
- Non Beta Powder for suspension block
- ORS Manufacturing area
All the above upgradation shall take 4-6 weeks. During this upgradation the production/activities shall remain partially suspended.
The upgradation would not only enable MBL to prepare for regulated market but also provide next level of growth in terms of good volume business with better margins.
Shares of MEDICAMEN BIOTECH LTD. was last trading in BSE at Rs.463 as compared to the previous close of Rs. 445.85. The total number of shares traded during the day was 2355 in over 72 trades.
The stock hit an intraday high of Rs. 464 and intraday low of 446. The net turnover during the day was Rs. 1073972.